Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis

[Image: see text] The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, providing critical research tools for cell-based studies that have been translated to in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Keck, Thomas M., John, William S., Czoty, Paul W., Nader, Michael A., Newman, Amy Hauck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516313/
https://www.ncbi.nlm.nih.gov/pubmed/25826710
http://dx.doi.org/10.1021/jm501512b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516313/
https://www.ncbi.nlm.nih.gov/pubmed/25826710
http://dx.doi.org/10.1021/jm501512b

Ejemplares similares